GH

GH P/E Ratio
P/E Ratio as of Oct 29, 2026: -52.95
Average-48.59
Median-47.98
Minimum-53.50
Maximum-45.11
-52.95
2.17 (4.27%)past month
The P/E ratio for GH is -52.95 as of Oct 29, 2026. This represents a increase of 43.38% compared to its 12-month average P/E ratio of -36.93. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Guardant Health Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Guardant Health Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Guardant Health Inc to industry peers.
Guardant Health Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Guardant Health Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Guardant Health Inc to industry peers.
GH P/E Ratio Insights
See Guardant Health Inc’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in GH
Order type
Buy in
Order amount
Est. shares
0 shares
GH P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Oct 1, 2026 | $174.75 | -49.93 |
| Sep 1, 2026 | $164.41 | -46.98 |
| Aug 3, 2026 | $158.83 | -45.38 |
| Jul 1, 2026 | $170.77 | -50.22 |
| Jun 1, 2026 | $129.14 | -37.98 |
| May 1, 2026 | $87.60 | -26.43 |
| Apr 1, 2026 | $91.15 | -27.50 |
| Mar 2, 2026 | $92.23 | -27.82 |
| Feb 2, 2026 | $114.90 | -35.76 |
| Jan 2, 2026 | $101.74 | -31.67 |
GH End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2026 | -52.95 | +66.56% |
| 2025 | -31.79 | +340.92% |
| 2024 | -7.21 | +8.42% |
| 2023 | -6.65 | +45.20% |
| 2022 | -4.58 | -81.67% |
| 2021 | -24.98 | — |
FAQs About Guardant Health Inc (GH) P/E ratio
The latest P/E ratio of GH is -52.95, as of Oct 29, 2026. This is calculated based on its current stock price and earnings per share (EPS).
Guardant Health Inc’s last 12-month average P/E ratio is -36.93, compared to its current P/E ratio of -52.95. This reflects a increase of 43.38%.
Guardant Health Inc’s current P/E ratio of -52.95 is higher than its last 12-month average P/E of -36.93. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Guardant Health Inc’s average P/E ratio over the last 3 years is -18.42. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Guardant Health Inc’s average P/E ratio over the last 5 years is -15.44. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.
GH P/E Ratio Insights
See Guardant Health Inc’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in GH
Order type
Buy in
Order amount
Est. shares
0 shares
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.